Assay for high glucose-mediated islet cell sensitization to apoptosis induced by streptozotocin and cytokines by Mellado-Gil, Jose M. & Aguilar-Diosdado, Manuel
 
 
 
 
 
© 2005 by the author(s). This paper is Open Access and is published in Biological Procedures Online under license from the author(s). Copying, 
printing, redistribution and storage permitted.  Journal © 1997-2005 Biological Procedures Online - www.biologicalprocedures.com 
Biol. Proced. Online 2005; 7(1): 162-171. 
doi:10.1251/bpo113 
November 7, 2005 
 
Assay for high glucose-mediated islet cell sensitization to apoptosis induced 
by streptozotocin and cytokines 
 
Jose M. Mellado-Gil1 and Manuel Aguilar-Diosdado1* 
 
1Endocrinology Service and Research Unit, Puerta del Mar Hospital, Cadiz, Spain. 
 
*Corresponding Author: Manuel Aguilar-Diosdado, Servicio de Endocrinologia. Hospital Puerta del Mar. Avda Ana de Viya nº 21 11009 Cadiz, Spain. 
Phone: +34 (9)56 002814; Fax: +34 (9)56 002315; Email: manuel.aguilar.sspa@juntadeandalucia.es 
 
Submitted: August 3, 2005; Revised: October 10, 2005; Accepted: October 11, 2005. 
 
Indexing terms: Apoptosis; Diabetes Mellitus; Streptozotocin; Cytokines. 
 
 
ABSTRACT 
 
Pancreatic β-cell apoptosis is known to participate in the β-cell destruction process that occurs in diabetes. It has been 
described that high glucose level induces a hyperfunctional status which could provoke apoptosis. This phenomenon 
is known as glucotoxicity and has been proposed that it can play a role in type 1 diabetes mellitus pathogenesis. In this 
study we develop an experimental design to sensitize pancreatic islet cells by high glucose to streptozotocin (STZ) and 
proinflammatory cytokines [interleukin (IL)-1β, tumor necrosis factor (TNF)-α and interferon (IFN)-γ]-induced 
apoptosis. This method is appropriate for subsequent quantification of apoptotic islet cells stained with Tdt-mediated 
dUTP Nick-End Labeling (TUNEL) and protein expression assays by Western Blotting (WB). 
 
 
INTRODUCTION 
 
Type 1 diabetes mellitus results from autoimmune T-cell-
mediated destruction of insulin-producing pancreatic 
islet  β-cells (1). Although the mechanism of how this 
destruction takes place is not completely understood, β-
cell apoptosis is known to participate in this process (2-
4). IL-1β alone or in combination with other 
proinflammatory cytokines inhibits the glucose-induced 
insulin secretion and plays an important role in β-cell 
death by inducing toxic nitric oxide (NO) production and 
extracellular signal-regulated kinase (ERK) activation in 
the islet (5-8). Streptozotocin (STZ) has been used widely 
to produce animal models of diabetes. The effects of STZ 
on β-cells are similar to those of IL-1β and also seem to 
be mediated by NO (9) through alkylation, DNA damage 
and poly-ADP ribose polymerase (PARP) activation (10). 
Furthermore, there are mounting evidences that have 
recently shown an important role of β-cell death in type 2 
diabetes mellitus (11).  
 
The pancreatic microenvironment can play an important 
function in β-cell death, making these cells more suscept- 
 
 
ible or resistant to damage. High glucose concentration 
impairs islet function by disturbing glucose metabolism 
in β-cells mitochondria and induces apoptosis (12-14). In 
addition, it has been reported that high glucose 
concentration could enhance ß-cell vulnerability to toxic 
effects by increasing the expression of potential 
autoantigens on the cell membrane surface (15).  
 
Based on the above-cited evidence, this study presents a 
method for the “in vitro” sensitization of islet cell, by 
using high subtoxic-to-toxic glucose concentrations, to 
STZ and cytokine-induced apoptosis. This method keeps 
the islets undamaged, so that, after trypsin dissociation, 
the cells can be stained by TUNEL. Also, the islets 
obtained were used to determine expression of 
apoptosis-related proteins like the cell death receptor Fas 
(CD95), Bcl-xL and Bcl-2, by WB. Fas seems to be 
implicated in β-cell apoptosis via an intracellular death 
domain (16) and proinflammatory cytokines can induce 
up-regulation of Fas expression on β-cells, making them 
susceptible to apoptosis in the presence of agonistic anti-
Fas antibodies or interaction with Fas-ligand (FasL, 
CD95L)-expressing T-cells (17-19). The role of Fas in β-    
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cell apoptosis is still under debate and has been 
challenged by several studies (20, 21). In addition, up-
regulation of several anti-apoptotic members of the Bcl-2 
family of proteins, such as Bcl-2 and Bcl-xL has been 
closely associated with increased resistance to apoptosis 
and potentially to diabetes susceptibility (22-24). The 
expression of these genes may possibly be modified by 
the functional status of the β-cell, especially when 
associated with a high glucose concentration. 
 
MATERIALS AND METHODS 
 
Isolation and culture of rat islets  
 
All animal procedures were performed with the 
approval of the Animal Ethical Use and Care Committee 
at the Cadiz University School of Medicine, Cadiz, Spain. 
Pancreatic islets were isolated from 200-250 g weight 
adult male Wistar rats, as described previously (25). In 
brief, animals were sacrificed and the pancreas was filled 
with a cold solution of colagenase P (1 mg/ml) in HBSS 
through a catheter introduced into the part of the 
choledoco running from the liver to the pancreas. Then 
the filled pancreas was extracted and digested at 37°C for 
20 min. while being agitated. Islets were isolated from 
the digested pancreas by density gradients, collected and 
cultured in Petri plates (100 islets on a 60 cm plate with 5 
ml of culture medium) with RPMI (Sigma, St Louis, MO) 
supplemented with 2 mM L-glutamine (Gibco,Invitrogen 
Limited, Paisley, UK), 10% fetal bovine serum (Gibco, 
Invitrogen Limited, Paisley, UK), 100 U/ml penicillin and 
100  µg/ml streptomycin (Pen-Strep; Bio-Whittaker 
Europe, Verviers, Belgium) and containing the 
established glucose concentration for each experiment. 
 
Sensitization protocol 
 
First, the glucose concentration adequate for islet cell 
sensitization was determined by a dose-response 
experiment. This was performed using 2, 5.5, 11.1, 24.4 
and 33.3 mM glucose and measuring different apoptosis 
rates by TUNEL-staining. The highest concentration 
which did not induce apoptosis “per se” was 24.4mM 
glucose; therefore this concentration was compared with 
5.5 mM which was considered as the optimal 
concentration. 
Sensitization to STZ-induced damage 
 
Islets were cultured for a sensitization period (48h) with 
RPMI-completed medium supplemented with 5.5 or 24.4 
mM glucose. After this period, the medium was 
replenished with fresh culture medium supplemented 
with 5.5. mM glucose for the all islets, maintaining the 
batches of islets separated according to the previous 
glucose concentration (during the sensitization period). 
Then STZ (Sigma, St Louis, MO) was added to the islet 
cultures for an incubation period of 24h. 
 
Sensitization to cytokine-induced damage 
 
Islets were cultured for an overnight period (≈14-16h) 
with RPMI-completed medium supplemented with 5.5 or 
24.4 mM glucose. The culture medium was replenished 
with fresh medium maintaining the glucose 
concentration either with IL-1β (PeproTech EC Ltd, 
London, UK) alone or with IL-1β + TNF-α (PeproTech 
EC Ltd., London, UK) + IFN-γ (PeproTech EC Ltd, 
London, UK). These alternative mixtures of medium 
were added to the islets cultured for a incubation period 
of 24h. The specific cytokine (50 U/ml IL-1β; 1,000 U/ml 
IFN-γ; 1,000 U/ml TNF-α) and STZ (1.5 mM) 
concentrations used in these experiments were selected 
from previous studies (26-28). 
 
Detection of apoptotic cells 
 
Apoptotic cells were detected using the TUNEL 
technique. Following treatment with cytokines or STZ, 
islets were incubated for 15 min with Trypsin-EDTA, 
0.25% trypsin, 1mM EDTA•4Na in Hanks´ balanced salt 
solution without Ca2+ and Mg2+(Gibco, Invitrogen 
Limited, Paisley, UK) at 37°C, and the islet cells were 
gently dispersed. After washing with PBS, the cells were 
cytospun on Poly-L-lysine-coated slides, fixed in 4% 
methanol-free formaldehyde solution in PBS for 25 min 
at 4°C, and stored in 70% ethanol at -20°C until detection 
of apoptotic cells by TUNEL assay. The TUNEL assay 
was performed according to the manufacturerʹs 
instructions (Apoptosis Detection System, Fluorescein; 
Promega Corporation, Madison, WI) (29). The 
fluorescein-12dUTP-labeled DNA was directly 
visualized by fluorescence microscopy with excitation at 
520  ± 20 nm, to allow counting of the proportion of 
apoptotic cells (nuclei with green fluorescence). Cell     
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nuclei were stained with propidium iodide (red 
fluorescence). Apoptotic and total nuclei were counted in 
a blinded fashion in two slides per condition and per 
experiment.  
 
Western blot 
 
Equal numbers of islets treated according to the various 
experimental conditions described above were lysed in 
60 mM Tris-HCl pH-6-8, 2% SDS, 10% glycerol, 0.0012% 
bromophenol blue, and 5% β-mercaptoethanol. Islet 
lysates were boiled for 5 minutes and then loaded on a 
10-12% SDS-polyacrylamide gel. An amount of 
lymphocytes of chronic lymphoid leukemia (CLL) 
equivalent to number of islet cells per condition were 
used as positive control for Bcl-2. Proteins were 
transferred to PDVF membrane and the blot was then 
incubated in blocking buffer (5% non-fat milk in 10 mM 
Tris-HCl, 1.15 M NaCl and 0.1% Tween-20) for 1h at 
room temperature. Next the blots were incubated with 
polyclonal antibodies against Fas (1:500 dilution; Santa 
Cruz Biotechnology Inc, Santa Cruz, CA), Bcl-xL (1:500 
dilution; Santa Cruz Biotechnology Inc, Santa Cruz, CA), 
Bcl-2 (1:100 dilution; Abcam Ltd, Cambridge, UK), or 
actin (1/5000 dilution; Abcam Ltd, Cambridge, UK) for 2 
h at room temperature, followed by incubation with the 
appropriate alkaline phosphatase-linked secondary 
antibody at room temperature for 1 h. Protein band 
detection was performed by adding 5-bromo-4-chloro-3-
indolyl phosphate/ nitroblue tetrazolium (BCIP/NBT; 
Bio-Rad Laboratories, Hercules, CA) to the membranes. 
Data from the densitometry of the bands was captured 
using BioCaptMW-[BioCaptMW-1] software. In each 
experiment, band densities were normalized against 
actin, and the results are expressed as protein level to 
control islets (C = 1). 
 
Statistical analysis 
 
Results are presented as mean ± S.E.M. in at least three 
independent and separate experiments. Statistical 
analysis was performed using the Mann-Whitney test 
and a P value less than 0.05 was considered statistically 
significant. 
RESULTS AND DISCUSSION 
 
Effect of glucose concentration on islet cell apoptosis 
 
It has recently been reported that chronic exposure to 
high glucose (for more than two days) leads to increased 
rat islet cell apoptosis (30). In the current study we first 
analyzed rat islet cell apoptosis in a glucose dose-
response curve for 48 h; an increased percentage of islet 
cell apoptosis was observed with low (2 mM) and very 
high (33.3 mM) glucose concentrations in the medium, 
but not with 5.5, 11.1 or 24.4 mM glucose (Fig. 1). 
 
 
Fig. 1: Glucose dose–response curve. The islets were cultured with 2, 5.5, 
11.1, 24.4 and 33.3 mM glucose for 48 h. Apoptotic cells were assessed 
by the TUNEL method under fluorescence microscopy. Data are expressed 
as the percentage of apoptotic cells. *P < 0.05 vs control 5.5 mM and P < 
0.05 vs control 11.1 mM. 
 
Effect of sensitization period on STZ-induced islet cell 
apoptosis 
 
Examination of TUNEL-stained cell preparations of islets 
maintained in 5.5 or 24.4 mM glucose for 48h and 
incubated with STZ for 24h was performed. We chose a 
dose of STZ that did not significantly increase rates of 
apoptosis in rat islet cells preincubated in 5.5mM glucose 
for 48h. Interestingly, apoptosis increased significantly 
(by 50%) when rat islets were incubated in 24.4mM 
glucose for 48 h with a low dose of STZ (1.5 mM) for an 
additional 24h period (Fig. 2). The rationale for STZ 
incubation with glucose 5.5 mM was to avoid 
competition between high glucose concentration and 
STZ for the glucose transporter GLUT-2 (31, 32).     
 
 
Mellado-Gil and Aguilar-Diosdado - Assay for high glucose-mediated islet cell sensitization to apoptosis induced by streptozotocin and cytokines 
www.biologicalprocedures.com 
165
 
Fig. 2: Influence of different glucose concentrations (5.5 or 24.4 mM) on 
islet cell apoptosis induced by STZ (1.5 mM). The islets were cultured 
either with 5.5 or 24.4 mM glucose and exposed to STZ. Apoptotic cells 
were assessed by the TUNEL method under fluorescence microscopy. 
Data are expressed as the percentage of apoptotic cells. Open bars, islets 
cultured with 5.5 mM glucose; filled bars, islets cultured with 24.4 mM 
glucose. *P < 0.05 vs control 24.4 mM glucose. 
 
Effect of sensitization period on cytokine-induced 
islet cell apoptosis  
 
We next analyzed whether high glucose also increases 
the sensitivity of rat islet cells to apoptosis induced by 
IL-1β+ TNF-α+ IFN-γ during the previous 24h. As shown 
i n  F i g .  3 ,  a  d o s e  o f  c y t o k i n e s  t h a t  d i d  n o t  i n d u c e  a  
significant increase in islet cell apoptosis at 5.5 mM 
glucose, was capable of inducing a significant two-fold 
increase in the apoptosis rates of islet cells maintained at 
24.4 mM glucose. Rates of apoptosis in islet cells 
incubated in high glucose rose from 6.09 ± 0.78% to 13.07 
± 1.78% (p < 0.01), when cytokines were added. This 
result indicates that the sensitization period at 24.4 mM 
glucose makes cells more susceptible to the apoptosis 
effects induced by cytokines. The percentage of apoptotic 
cell in islets incubated with high glucose concentration 
(24.4 mM) and cytokines were significantly higher than 
in islets with cytokines but incubated in 5.5 mM glucose 
(13.07 ± 1.78% vs. 8.04 ± 1.56% (p < 0.05). Interestingly, 
this effect was only observed when the three cytokines 
were used in combination, since IL-1ß alone did not 
induce a significant increase in apoptosis at any glucose 
concentration tested. Collectively, these results suggest 
that although incubation for 48h with high glucose does 
not induce an increase in rat islet cell apoptosis, it 
potentiates the pro-apoptotic effects of cytokines and 
STZ. 
 
Fig. 3: Influence of different glucose concentrations (5.5 or 24.4 mM) on 
islet cell apoptosis induced by IL-1β and combined cytokines (IL-1β +IFN-γ 
+TNF-α). A. Representative microscopy images of apoptotic cells stained 
with TUNEL (green) and Propidium Iodide (red). 5.5 mM glucose control 
(upper left); 5.5 mM glucose with cytokines (upper right); 24.4mM glucose 
control (bottom left) and 24.4mM glucose exposed to cytokines (bottom 
right). Arrows indicate apoptotic cells (co-location of red fluorescence of 
all cells plus green fluorescence of apoptotic cells). B. Percentage of 
apoptotic cells cultured with 5.5 or 24.4 mM glucose and exposed to IL-1β 
and combined cytokines. Open bars, islets cultured with 5.5 mM glucose; 
filled bars, islets cultured with 24.4 mM glucose. *P < 0.01 vs control 
24.4 mM glucose and P < 0.05 vs. cytokines with 5.5 mM glucose. 
 
Effect of sensitization period with high glucose on the 
expression of apoptosis-related proteins 
 
Fas is a death receptor involved in apoptosis in various 
cell types including islet cells (16-19). To determine 
whether glucose concentration has any impact in the 
expression of Fas in rat islet cells treated either with 
cytokines or STZ, we performed WB analysis of islet 
extracts incubated with the cell-death inducers in normal 
(5.5 mM) and high (24.4mM) glucose concentrations. As 
it is shown in Figs. 4 and 5, incubation in high glucose for 
48 h induced a significant increase (p < 0.05) in the     
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expression of Fas which was not modified when an 
incubation period with cytokines (Fig. 4) or STZ (Fig. 5) 
was performed. These results indicate that the 
sensitization period induces an increase in the expression 
of Fas in rat islet cells that is not associated with a rise in 
apoptosis. Moreover, high glucose potentiation of the 
apoptotic effects of cytokines and STZ does not correlate 
with an increase in Fas expression. 
 
 
Fig. 4: Fas (CD95) expression in rat islets after exposure to IL-1β and 
combined cytokines (IL-1β, TNF-γ, IFN-α). (A) Immunoblotting of Fas. Islets 
were cultured overnight with 5.5 or 24.4 mM glucose and exposed to IL-
1β alone or combined with TNF-α plus IFN-γ, for 24 h. Antibodies against 
Fas and actin were blotted in the same filter after stripping. One of at 
least three experiments is shown. Each experiment gave similar results. C, 
control; IL-1β, interleukin-1β; CTK, cytokines (IL-1β + TNF-α + IFN-γ). (B) 
Densitometric quantitation of Fas-to-actin ratio showed a significant 
difference between 5 mM and 24.4 mM in the three groups (control, IL-1 
and CTK). Y-axis represents arbitrary units. Open bars, islets cultured with 
5.5 mM glucose; filled bars, islets cultured with 24.4 mM glucose. *P< 
0.05 vs control, 5.5 mM glucose; **P < 0.05 vs. interleukin-1β, 5.5 mM 
glucose; *** P < 0.05 vs. cytokines, 5.5 mM glucose. 
 
The anti-apoptotic proteins Bcl-xL and Bcl-2 expression 
were also studied after preculture with high glucose and 
treatment with the cytotoxic agents. As shown in Figures 
6 and 7, we did not find any significant difference in the 
expression of either Bcl-xL or Bcl-2 in islets cultured at 
high or normal glucose concentration and treatment with 
cytokines (Fig. 6) or STZ (Fig. 7). However, while Bcl-xL 
was clearly detected, Bcl-2 was scarcely visible in all the 
conditions studied. As it has been described previously, 
basal expression of bcl-2 protein in pancreas islets seems 
to be very low and difficult to detect by WB (33, 34).  
 
 
Fig. 5: Expression of Fas (CD95) in rat islets after exposure to STZ. (A) 
Immunoblotting of Fas. Islets were cultured for 48 h with 5.5 or 24.4 mM 
glucose and exposed to STZ for 24 h. Antibodies against Fas and actin 
were blotted in PVDF after stripping. One of at least three experiments is 
shown. Each experiment gave similar results. (B) Densitometric 
quantitation of Fas-to-actin ratio showed a significant difference between 
5 mM and 24.4 mM. Y-axis represents arbitrary units. Open bars, islets 
cultured with 5.5 mM glucose; filled bars, islets cultured with 24.4 mM 
glucose. *P < 0.05 vs control, 5.5 mM glucose. 
 
However, the expression of other apoptosis-related genes 
could be analyzed after following the islet culture 
procedure shown in this work. Further studies will be 
required to clarify the molecular mechanisms responsible 
for the high-glucose enhancement of islet cell apoptosis 
induced by cytokines and STZ. 
 
 
Fig. 6: Expression of Bcl-2 and Bcl-xL in rat islets after exposure to IL-1β 
and combined cytokines (IL-1β + TNF-γ + IFN-α). Islets were cultured 
overnight with 5.5 or 24.4 mM glucose and exposed to IL-1β alone or 
combined cytokines for 24 h. Immunoblottings were performed using 
antibodies against Bcl-2 and Bcl-xL. Actin levels were determined as 
loading control. Densitometric quantitation of both Bcl-2 and Bcl-xL-to-
actin ratio did not generate significant differences (data not shown). One 
of at least three experiments is shown. Each experiment gave similar 
results. An amount of lymphocytes of chronic lymphoid leukemia (CLL) 
equivalent to number of islet cells per condition were used as positive 
control for Bcl-2. C, control; IL-1β, interleukin-1β; CTK, cytokines (IL-1β + 
TNF-α + IFN-γ). 
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Fig. 7: Expression of Bcl-2 and  Bcl-xL in rat islets after exposure to STZ. 
(A) Immunoblotting of Bcl-2, Bcl-xL and Fas. Islets were cultured for 48 h 
with 5.5 or 24.4 mM glucose and exposed to STZ for 24 h. The antibodies 
were blotted in different PVDF filters and antiactin after stripping was 
used for loading control. Densitometric quantitation of both Bcl-2 and Bcl-
xL-to-actin ratio did not generate significant differences (data not shown). 
One of at least three experiments is shown. Each experiment gave similar 
results. An amount of lymphocytes of chronic lymphoid leukemia (CLL) 
equivalent to number of islet cells per condition were used as positive 
control for Bcl-2. 
  
Conclusion 
 
It is not well known whether high glucose concentration 
has any role in the apoptosis induced by STZ and 
cytokines in islet cells. We have designed an 
experimental method to assess the influence of glucose 
concentration on the effects of toxic agents classically 
involved in β-cell death and to analyze whether rat islet 
cell apoptosis induced by recognized islet cell toxic 
agents such as proinflammatory cytokines (IL-1β, TNF-α, 
IFN-γ) or STZ may be modulated by a pretreatment with 
high glucose concentration. In the study described here, 
we demonstrate that the presence of high glucose 
concentration in a preculture period enhances 
proinflammatory cytokine- and STZ-mediated apoptosis 
of rat pancreatic islet cells in vitro. Our results suggest 
that mechanisms involved in cytokine-induced apoptosis 
could be more amplified by the high glucose-induced 
hyperfunctional status of islet cells than the mechanisms 
implicated in STZ-mediated apoptosis. This effect could 
also be partially explained by recently reported glucose-
induced IL-1β production by β-cells (35). Some of the 
differences between our study and others could be due 
to species, time course, glucose concentration in the 
culture media and experimental models used. Thus, 
although murine dispersed islet cells survive best at 11 
mM glucose and apoptosis increases when glucose is 
increased or decreased (29), we show a similar U-shape 
curve but no differences between 5.5, 11 and 24.4 mM in 
whole rat islets. It is interesting to note that neither high 
glucose concentration nor the toxic agents used in this 
study caused marked apoptosis when used separately, 
and the higher levels of apoptosis were found when high 
glucose and cytokines, or STZ, existed simultaneously.  
Our experimental design appears to be a feasible method 
for evaluating the influence of glucose on several stimuli 
causing β-cell damage and it seems to be adequate for 
determining synergistic and/or sensitization 
relationships between the effects of both high glucose 
concentration and potentially β-cells toxic agents (36). 
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PROTOCOLS 
 
Rat islet isolation 
 
1.  Kill animal by an appropriate method. 
2.  Open the abdominal cavity. 
3.  Close choledoco exit to the intestine by clamping. 
4.  Introduce a catheter into the part of the choledoco running from the liver to the pancreas. 
5.  Connect the catheter to a syringe and inject 15-20 ml of a cold solution of colagenase P (1 mg/ml) in HBSS until the 
pancreas is full. 
6.  Extract the filled pancreas by cutting out around the edges. 
7.  Incubate for 17-20 min at 37°C in agitation. 
8.  Homogenize the preparation with a pasteur pipette and add 60 ml of HBSS+ BSA (1 mg/ml). 
9.  After 5-8 min placed in ice without movement, aspirate 15-20 ml from the surface to eliminate fat and other 
floating debris. 
10.  Pass through a strainer to eliminate non digested tissue and then into a 50 ml tube. 
11.  Centrifuge for 5 min, at 1000 rpm, 4°C and reject the supernatant. 
12.  Add to the “pellet” 10 ml. of Histopaque 1119 and resuspend. Put into 10 ml of Histopaque 1077 and 10 ml of 
HBSS+ BSA to form a density gradient. 
13.  Centrifuge for 20-25 min, at 2000 rpm, 4°C. 
14.  Take the interphase between Histopaque 1077 and HBSS+ BSA (10- 15 ml) and put it in a 50 ml tube. 
15.  Fill to 50 and wash by centrifuging for 5 min, at 100 rpm, 4°C. 
16.  Aspirate 30 ml of supernatant, homogenize the islet suspension gently with a pipette and put onto a black Petri 
plate. 
17.  Using the stereo microscope and micropipette, collect 100-150 islets on each 60 cm culture plate with 5 ml of 
culture medium). 
 
Sensitization protocol 
 
Sensitization to STZ-induced damage: 
 
1.  Culture islets for a sensitization period of 48h with RPMI-completed medium supplemented with 5.5 or 24.4 mM 
glucose. 
2.  Replace medium with fresh culture medium supplemented with 5.5 mM glucose for the all islets, maintaining 
separated the batches of islets according to the previous glucose concentration (during the sensitization period). 
3.  Add STZ to islet cultures. 
4.  Culture for 24h. 
 
 
 
 
 
     
 
 
Mellado-Gil and Aguilar-Diosdado - Assay for high glucose-mediated islet cell sensitization to apoptosis induced by streptozotocin and cytokines 
www.biologicalprocedures.com 
171
Sensitization to cytokine-induced damage: 
 
1.  Culture islets for an overnight period (≈14-16h) with RPMI-completed medium supplemented with 5.5 or 24.4 mM 
glucose. 
2.  Replace with fresh medium maintaining both glucose concentrations.  
3.  Add IL-1β (50 U/ml) alone or IL-1β + TNF-α (1000 U/ml) + IFN-γ (1000 U/ml). 
4.  Culture for an incubation period of 24h. 
 
 
 